| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0275 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0275 |
| filingDate |
2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_034a487ba8b3290c0ceab0589a00ea45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c37f690dfa23fc933634eab63d6ea89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cd3850d761dc7948e4c2bce1e792dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c36458d7d356df245c5297295c69ede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a22c070ae8d97db927ed8d9e1907eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6fca91cbaf8125bcf309cf9ffd5931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7195be2d1f04fafc77ea9e522f565775 |
| publicationDate |
2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015201881-A1 |
| titleOfInvention |
Method and device for assisting in the assessment of rheumatism treatments |
| abstract |
A method is disclosed for determining analysis information supporting a user assessing the effect of a biological agent on the treatment of a rheumatic disease. The method includes, subsequent to starting the administration of the biological agent: recording a first morphological magnetic resonance imaging record of at least one target joint using a first magnetic resonance sequence; recording a second magnetic resonance imaging record showing the blood flow through the target joint by perfusion imaging using a second magnetic resonance sequence; determining at least a first measuring parameter related to the morphology of the joint by analysis of the first magnetic resonance imaging record and at least a second measuring parameter describing the blood flow in the target joint by analysis of the second magnetic resonance imaging record; and automatic determination of the analysis information from the first and the second measuring parameter. |
| priorityDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |